Pharmaceutical Articles

Beasley Allen has one of the largest and most technologically advanced Mass Torts practices in the country. The Mass Torts division represents numerous people in claims against companies that manufacture and/or market defective pharmaceuticals and/or medical devices. The resources devoted to this division allow the firm to competently and conscientiously handle any group of cases, no matter how large, along with particular catastrophic injury cases.

Our firm was recently involved in one of the greatest victories in Mass Torts history, against drug manufacturer Merck regarding the drug Vioxx. After more than five years of hard-fought and difficult litigation, Merck agreed to pay $4.85 billion, the largest pharmaceutical settlement in U.S. history, to resolve certain Vioxx-related claims involving plaintiffs who suffered a heart attack, including sudden cardiac death, or a stroke.

FDA warns of serious risks associated with epidural injections of corticosteroids

Posted: April 24, 2014

Injections of corticosteroids into the epidural space of the spine may cause rare but serious side effects including vision loss, stroke, paralysis and death, the Food and Drug Administration (FDA) warned. The injections are given to treat neck and back

Some diabetes drugs may be linked to more serious side effects than initially thought

Posted: April 24, 2014

Type 2 diabetes drugs known as DPP-4 inhibitors may be linked to more serious side effects than generally believed, according to an analysis from AdverseEvents.

Could ‘Low T’ treatments be dangerous to your health?

Posted: April 23, 2014

If you’re a man and you listen to the advertisements from some drug makers describing a condition known as “Low T” with symptoms such as low libido, zapped energy levels, weight gain and muscle loss, you might be tempted to

Too many children prescribed codeine despite black box warnings

Posted: April 23, 2014

At least a half million children are prescribed medications containing the potent painkiller codeine during emergency room visits each year despite warnings that the drug be used sparingly in children because it can be fatal in some circumstances, according to

Alabama residents with Type 2 diabetes sought for long-term study on medication effectiveness

Posted: April 22, 2014

Researchers at the University of Alabama at Birmingham (UAB) are enrolling participants in an ongoing study on the long-term benefits and side effects with certain combinations of drugs to treat type 2 diabetes.

Vials of injectable sleep drug Propofol recalled

Posted: April 22, 2014

Hospira is recalling seven lots of Propofol Injectable Emulsion, an anesthetic used to put people to sleep before and during surgeries, due to visible metal particles floating in glass vials of the solution.

Participants sought to test long-term effects of popular type 2 diabetes drugs

Posted: April 21, 2014

Researchers at Washington University School of Medicine in St. Louis are seeking volunteers to participate in a study comparing the long-term risks and benefits of four widely prescribed diabetes drugs. The medications will be given in combination with the widely

Mildly low testosterone levels do not typically require replacement therapy

Posted: April 21, 2014

Testosterone replacement therapy may be recommended to treat men with very low testosterone levels but it is not typically recommended for older men who are otherwise healthy even if their hormone levels are slightly below what is considered normal, according

New products, studies could make intrauterine birth control devices more popular

Posted: April 20, 2014

Intrauterine devices, or IUDs, are considered a highly effective contraceptive device and more convenient than a once-a-day birth control pill. New products and studies currently underway may make them even more popular in the years to come, according to RH

Recent actions call into question whether Fresenius cares about patient safety

Posted: April 20, 2014

Recent actions by Fresenius Medical Care suggest the world’s largest provider of dialysis products and services may not be too concerned about patient safety.